A Case of Complete Remission of Glucocorticoid-Dependent Nephrotic Syndrome after Targeted-Release Formulation of Budesonide Treatment in a Patient with Mild Mesangial Proliferative IgA Nephropathy

Efstathios Mitsopoulos, Panagiotis Pateinakis, Christodoulos Keskinis, Dorothea Papadopoulou

Open source

DOI
10.1159/000543271
Published
2024-12-23
Container
Nephron
Publisher
S. Karger AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1159/000543271,
  title = {A Case of Complete Remission of Glucocorticoid-Dependent Nephrotic Syndrome after Targeted-Release Formulation of Budesonide Treatment in a Patient with Mild Mesangial Proliferative IgA Nephropathy},
  author = {Efstathios Mitsopoulos and Panagiotis Pateinakis and Christodoulos Keskinis and Dorothea Papadopoulou},
  year = {2024},
  journal = {Nephron},
  doi = {10.1159/000543271},
  url = {https://doi.org/10.1159/000543271}
}

RIS

TY  - JOUR
TI  - A Case of Complete Remission of Glucocorticoid-Dependent Nephrotic Syndrome after Targeted-Release Formulation of Budesonide Treatment in a Patient with Mild Mesangial Proliferative IgA Nephropathy
AU  - Efstathios Mitsopoulos
AU  - Panagiotis Pateinakis
AU  - Christodoulos Keskinis
AU  - Dorothea Papadopoulou
PY  - 2024
JO  - Nephron
DO  - 10.1159/000543271
UR  - https://doi.org/10.1159/000543271
ER  - 

APA

Mitsopoulos, E., Pateinakis, P., Keskinis, C., & Papadopoulou, D. (2024). A Case of Complete Remission of Glucocorticoid-Dependent Nephrotic Syndrome after Targeted-Release Formulation of Budesonide Treatment in a Patient with Mild Mesangial Proliferative IgA Nephropathy. Nephron. https://doi.org/10.1159/000543271

Source records